Richard I. Steinhart, CFO: BioXcel Therapeutics BTAIQ Sell · Filed 23/03/16

Trade details

Type: Insider sale
Amount: $40,638
Shares · price: 2,084 sh · $19.50 a share
Held after: 1,500 sh
Stock: BioXcel Therapeutics BTAIQ
Person: Richard I. SteinhartCFO
Trade date: 23/03/15
Filed: 23/03/16
Days to filing: 1 days

Sold 58.1% of holdings

Share of holding sold: 58.1%

BioXcel Therapeutics trades, last 26 weeks

What else happened in BioXcel Therapeutics around then

Filed or reported within 30 days of the trade day · 23/02/13~23/04/14

Richard I. Steinhart's recent trades

Richard I. SteinhartCFO
Sell10b5-1 planBioXcel Therapeutics
Sell10b5-1 plan
BioXcel Therapeutics
BTAIQ
$7,461
6,845 sh
$7,461
Filed 05/22
Traded 05/20
Richard I. SteinhartCFO
Planned sale10b5-1 planBioXcel Therapeutics
Planned sale10b5-1 plan
BioXcel Therapeutics
BTAIQ
$7,426
6,845 sh
$7,426
Filed 05/20
Traded 05/20
Richard I. SteinhartCFO
Sell10b5-1 planBioXcel Therapeutics
Sell10b5-1 plan
BioXcel Therapeutics
BTAIQ
$74
205 sh
$74
Filed 24/12/17
Traded 24/12/16
Richard I. SteinhartCFO
Sell10b5-1 planBioXcel Therapeutics
Sell10b5-1 plan
BioXcel Therapeutics
BTAIQ
$134
372 sh
$134
Filed 24/12/17
Traded 24/12/16
Richard I. SteinhartCFO
Sell10b5-1 planBioXcel Therapeutics
Sell10b5-1 plan
BioXcel Therapeutics
BTAIQ
$3,946
7,175 sh
$3,946
Filed 24/10/03
Traded 24/10/03

Richard I. Steinhart, CFO — sold $40.6K of BioXcel Therapeutics BTAIQ · 58.1% of holdings | Whalegun